Related Experiment Video
Updated: May 30, 2026
07:41
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
A TeNaCious foundation for the metastatic niche.
Irina Matei1, Cyrus M Ghajar, David Lyden
1Departments of Pediatrics and Cell and Developmental Biology, Weill Cornell Medical College, New York, NY 10021, USA.
Cancer Cell
|August 16, 2011
Summary
Tenascin C, an extracellular matrix protein, plays a dual role in breast cancer lung metastasis. Targeting tenascin C may disrupt the metastatic niche and inhibit cancer spread.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- The extracellular matrix (ECM) plays a critical role in cancer progression and metastasis.
- Specific ECM components can create supportive niches for tumor cells at secondary sites.
- Understanding the role of ECM proteins in metastasis is crucial for developing targeted therapies.
Purpose of the Study:
- To elucidate the role of tenascin C (TNC) in the metastatic niche formation during breast cancer lung colonization.
- To investigate the biphasic function of TNC in supporting or hindering cancer cell metastasis.
Main Methods:
- Utilized mouse models of breast cancer lung metastasis.
- Analyzed the expression and localization of tenascin C in the lung metastatic microenvironment.
- Investigated the impact of tenascin C modulation on breast cancer cell colonization and outgrowth.
Main Results:
- Identified a biphasic role for tenascin C in breast cancer lung metastasis.
- Tenascin C promotes the initial colonization of breast cancer cells in the lung.
- Conversely, tenascin C inhibits the subsequent outgrowth of established lung metastases.
Conclusions:
- Tenascin C acts as a critical component of the metastatic niche, influencing both the establishment and progression of lung metastases.
- These findings suggest that tenascin C could be a therapeutic target to disrupt the metastatic process in breast cancer.
- Targeting tenascin C may offer a novel strategy to inhibit metastatic progression by dismantling the supportive microenvironment.
Related Concept Videos
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
01:35Cancer Cell Migration through Invadopodia
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...